Novo Nordisk wins big on strong US dollar

The sharply rising US dollar exchange rate compared to the Danish krone is very lucrative for Danish firms. Novo Nordisk is the clear winner, but many other healthcare companies also stand to benefit.
Photo: Jacob Gronholt-Pedersen/REUTERS / X04292
Photo: Jacob Gronholt-Pedersen/REUTERS / X04292
by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen

Danish business, with pharmaceutical flagship Novo Nordisk at the forefront, is winning big on a dramatic rise in the US dollar exchange rate.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading